Litcius/Paper detail

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

Adolfo Aleman, Oliver Van Oekelen, David T. Melnekoff, Leah Grossman, Tarek H. Mouhieddine, Agata Kurowski, Ivan Odak, Sidorela Reci, Shilpa Desai, Shannon Meledathu, Malini P. Naidu, Ravi Prakash Shukla, Rudra Prasad Dutta, Katerina Kappes, Kseniya Serebryakova, Hayley Jackson, Jordan Lu, Anastasia Chatikhine, Raksha Kulkarni, Zahra Moinfar, Matthew McKnight Croken, Meenakshi Mehrotra, Brett Baskovich, Sampanna Rayamajhi, Shambavi Richard, Adriana Rossi, Christian Salib, Jane Houldsworth, Brian D. Brown, Miriam Mérad, Alessandro Laganà, Patrick M. Brunner, Sundar Jagannath, Joshua Brody, Samir Parekh

2025New England Journal of Medicine14 citationsDOIOpen Access PDF

Topics & Concepts

CAR T-cell therapyLymphomaMedicineCell therapyTargeted therapyChimeric antigen receptorOncologyCancer researchCellT cellInternal medicineImmunologyCancerBiologyImmune systemGeneticsCAR-T cell therapy researchLymphoma Diagnosis and TreatmentViral Infectious Diseases and Gene Expression in Insects
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy | Litcius